World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
66
Citations
18858
World Ranking
2733
National Ranking
25

Jinlin Hou publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jinlin Hou sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 414 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jinlin Hou D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jinlin Hou sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jinlin Hou is a researcher affiliated with Southern Medical University in China, specializing in medicine with a significant focus on hepatology and related fields. Their body of work spans several interconnected areas including epidemiology, infectious diseases, molecular biology, and immunology.

Their research primarily revolves around key topics such as Hepatitis B Virus Studies, Hepatitis C virus research, and liver disease diagnosis and treatment. Additional focus areas comprise hepatocellular carcinoma treatment and prognosis, hepatitis viruses studies and epidemiology, cancer genomics and diagnostics, and liver disease and transplantation.

Among notable recent papers authored by or associated with scientists in their circle are:

  • "Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China," 2020, published in Nature Medicine
  • "Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)," 2023, published in Liver Cancer
  • "aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis," 2020, published in Journal of Hepatology
  • "Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection," 2022, published in New England Journal of Medicine
  • "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)," 2023, published in Journal of Clinical and Translational Hepatology

Jinlin Hou frequently collaborates with several researchers in their field, including:

  • Jian Sun
  • Rong Fan
  • Xieer Liang
  • Bin Zhou
  • Junqi Niu

Their publications are commonly found in specific scientific venues known for hepatology and clinical research, such as:

  • Journal of Hepatology
  • Journal of Clinical and Translational Hepatology
  • Alimentary Pharmacology & Therapeutics
  • PubMed
  • Journal of Medical Virology

Jinlin Hou's expertise in epidemiology underpins much of their research on infectious diseases related to liver health. With a strong emphasis on clinical applications and guidelines, their work contributes to understanding liver cancer, hepatitis infections, and treatment outcomes.

Best Publications

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • Epidemiology and Prevention of Hepatitis B Virus Infection.

    Jinlin Hou;Zhihua Liu;Fan Gu

  • Hepatocellular carcinoma in the Asia Pacific region.

    Man-Fung Yuen;Jin-Lin Hou;Anuchit Chutaputti

  • Therapeutic strategies for hepatitis B virus infection: towards a cure

    Gregory C Fanning;Fabien Zoulim;Jinlin Hou;Antonio Bertoletti

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

    Xin Xu;Jian Sun;Sheng Nie;Huiyuan Li

  • Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.

    Jie Wang;Tao Shen;Xiangbo Huang;G. Renuka Kumar

  • Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

    Qin Ning;Meifang Han;Yongtao Sun;Jiaji Jiang

  • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.

    Rong Fan;George Papatheodoridis;Jian Sun;Hamish Innes

  • [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update].

    Jin-Lin Hou;Wei lai

  • Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

    Stefan Zeuzem;Edward Gane;Yun Fan Liaw;Seng G. Lim

  • Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

    Jinlin Hou;Guiqiang Wang;Fusheng Wang;Jun Cheng

  • Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

    George Ka-Kit K. Lau;Manuel Tsiang;Jinlin Hou;Siu-Tsan Yuen

  • Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial†‡

    Jinlin Hou;You-Kuan Yin;Daozhen Xu;Deming Tan

  • Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

    Zhanhui Wang;Jin Zhang;Hong Yang;Xiuhui Li

  • Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents.

    Cheng Wang;Dong Ji;Jing Chen;Qing Shao

  • Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.

    Yue Hy;Yin C;Hou Jl;Zeng X

  • qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients

    Shuoyu Xu;Yan Wang;Yan Wang;Dean C.S. Tai;Shi Wang

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection.

    Zhihua Liu;Jinlin Hou

  • Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

    GC Farrell;HL Chan;Rmf Yuen;DN Amarapurkar

  • A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China.

    Zhanhui Wang;Zhihua Liu;Guobing Zeng;Shujuan Wen

Frequent Co-Authors

Hui Zhuang
Hui Zhuang Peking University
Zhihua Liu
Zhihua Liu Peking Union Medical College Hospital
Nikolai V. Naoumov
Nikolai V. Naoumov Novartis (Switzerland)
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Henry Lik-Yuen Chan
Henry Lik-Yuen Chan Chinese University of Hong Kong
Zhihong Liu
Zhihong Liu Nanjing University
Jun Cheng
Jun Cheng University of Chinese Academy of Sciences
Mengji Lu
Mengji Lu University of Duisburg-Essen
Bettina E. Hansen
Bettina E. Hansen University Health Network
Hao Wang
Hao Wang Swinburne University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring immunology, understanding related healthcare degrees can open diverse career pathways. Many professionals interested in patient care or research often consider online nursing programs for non nurses, which offer a flexible way to enter the nursing field without prior nursing experience.

Accelerated BSN programs for non nurses are another popular option for those looking to fast-track their nursing education. These programs typically build on previous academic achievements, allowing students to complete their Bachelor of Science in Nursing in a shorter timeframe compared to traditional routes.

For individuals seeking quicker entry into the healthcare workforce, easy admission LPN programs provide accessible routes to becoming licensed practical nurses. These programs focus on foundational nursing skills and are designed to be approachable for students from various backgrounds.

Additionally, what is the easiest NP program is a common query for those aiming to become nurse practitioners with advanced clinical roles. These programs often balance rigorous training with streamlined admission processes to accommodate working professionals.

Exploring these related degrees offers flexible and practical options that complement immunology expertise, expanding career prospects in healthcare and biomedical sciences.

Best Scientists Citing Jinlin Hou

Trending Scientists